These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 5665061)

  • 21. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiopharmaceutical production--radiation safety.
    Fredrickson RL; Myers CB
    IMS Ind Med Surg; 1969 Jul; 38(7):199-204. PubMed ID: 5256328
    [No Abstract]   [Full Text] [Related]  

  • 23. GMPs vs GCPs: United States Pharmacopeia General Chapters.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
    [No Abstract]   [Full Text] [Related]  

  • 24. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 25. Adequate and sensible quality control.
    Schoulund B
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:21. PubMed ID: 5701294
    [No Abstract]   [Full Text] [Related]  

  • 26. Problems Associated With Some Drug Formulations.
    Paul Y
    Indian Pediatr; 2019 Jun; 56(6):513-514. PubMed ID: 31278243
    [No Abstract]   [Full Text] [Related]  

  • 27. Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging.
    Allen LV
    Int J Pharm Compd; 2012; 16(5):405-14. PubMed ID: 23072201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 29. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 30. [Practical realization of manufacturing control in Switzerland].
    Witschi T
    Pharm Acta Helv; 1972; 47(11):637-47. PubMed ID: 4657533
    [No Abstract]   [Full Text] [Related]  

  • 31. Think about drug packaging.
    Prescrire Int; 2012 Dec; 21(133):284. PubMed ID: 23373090
    [No Abstract]   [Full Text] [Related]  

  • 32. [The Veterinary Service Board. Animal drug legislation. Packaging and labelling of animal drugs].
    Tijdschr Diergeneeskd; 1988 Sep; 113(18):1031-2. PubMed ID: 3176008
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 34. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 35. Single dose medication vial packaging deficiencies.
    Craig DB; Martens DJ; Embil JM
    Can J Anaesth; 1998 Jun; 45(6):501-8. PubMed ID: 9669001
    [No Abstract]   [Full Text] [Related]  

  • 36. [Patient and drug packaging].
    Sloot HA
    Ned Tijdschr Geneeskd; 1979 May; 123(19):791-802. PubMed ID: 440465
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of vendors and drug-product selection.
    Dedrick SC; Eckel FM
    Am J Hosp Pharm; 1984 Apr; 41(4):703-8. PubMed ID: 6720713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial content in non-sterile pharmaceuticals. I. Introduction.
    Dan Tidsskr Farm; 1968; 42(1):1-4. PubMed ID: 4968767
    [No Abstract]   [Full Text] [Related]  

  • 39. On the accountability problem of the pharmaceutical industry.
    Roberts CD
    Pharmazie; 1973 Jan; 28(1):49-51. PubMed ID: 4714241
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug defect reporting program.
    Valentino JG
    Bull Parenter Drug Assoc; 1975; 29(2):55-63. PubMed ID: 1120213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.